Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

MicroRNA-26 was decreased in rat cardiac hypertrophy model and may be a promising therapeutic target.

Zhang ZH, Li J, Liu BR, Luo CF, Dong Q, Zhao LN, Zhong Y, Chen WY, Chen MS, Liu SM.

J Cardiovasc Pharmacol. 2013 Sep;62(3):312-9. doi: 10.1097/FJC.0b013e31829b82e6.

PMID:
23719092
[PubMed - indexed for MEDLINE]
2.

MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts.

Curcio A, Torella D, Iaconetti C, Pasceri E, Sabatino J, Sorrentino S, Giampà S, Micieli M, Polimeni A, Henning BJ, Leone A, Catalucci D, Ellison GM, Condorelli G, Indolfi C.

PLoS One. 2013 Jul 26;8(7):e70158. doi: 10.1371/journal.pone.0070158. Print 2013.

PMID:
23922949
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling.

Karakikes I, Chaanine AH, Kang S, Mukete BN, Jeong D, Zhang S, Hajjar RJ, Lebeche D.

J Am Heart Assoc. 2013 Apr 23;2(2):e000078. doi: 10.1161/JAHA.113.000078.

PMID:
23612897
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy.

Dong DL, Chen C, Huo R, Wang N, Li Z, Tu YJ, Hu JT, Chu X, Huang W, Yang BF.

Hypertension. 2010 Apr;55(4):946-52. doi: 10.1161/HYPERTENSIONAHA.109.139519. Epub 2010 Feb 22.

PMID:
20177001
[PubMed - indexed for MEDLINE]
Free Article
5.

MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.

Ganesan J, Ramanujam D, Sassi Y, Ahles A, Jentzsch C, Werfel S, Leierseder S, Loyer X, Giacca M, Zentilin L, Thum T, Laggerbauer B, Engelhardt S.

Circulation. 2013 May 28;127(21):2097-106. doi: 10.1161/CIRCULATIONAHA.112.000882. Epub 2013 Apr 26.

PMID:
23625957
[PubMed - indexed for MEDLINE]
Free Article
6.

A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling.

Nagalingam RS, Sundaresan NR, Gupta MP, Geenen DL, Solaro RJ, Gupta M.

J Biol Chem. 2013 Apr 19;288(16):11216-32. doi: 10.1074/jbc.M112.442384. Epub 2013 Feb 27.

PMID:
23447532
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes.

Song XW, Li Q, Lin L, Wang XC, Li DF, Wang GK, Ren AJ, Wang YR, Qin YW, Yuan WJ, Jing Q.

J Cell Physiol. 2010 Nov;225(2):437-43. doi: 10.1002/jcp.22217.

PMID:
20458739
[PubMed - indexed for MEDLINE]
8.

Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy.

Li Q, Song XW, Zou J, Wang GK, Kremneva E, Li XQ, Zhu N, Sun T, Lappalainen P, Yuan WJ, Qin YW, Jing Q.

J Cell Sci. 2010 Jul 15;123(Pt 14):2444-52. doi: 10.1242/jcs.067165. Epub 2010 Jun 22. Erratum in: J Cell Sci. 2010 Aug 1;123(Pt 15):2680.

PMID:
20571053
[PubMed - indexed for MEDLINE]
Free Article
9.

Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.

Huang Y, Wu D, Zhang X, Jiang M, Hu C, Lin J, Tang J, Wu L.

Gene. 2014 Feb 25;536(2):225-31. doi: 10.1016/j.gene.2013.12.052. Epub 2013 Dec 27.

PMID:
24378234
[PubMed - indexed for MEDLINE]
10.

The miR-19a/b family positively regulates cardiomyocyte hypertrophy by targeting atrogin-1 and MuRF-1.

Song DW, Ryu JY, Kim JO, Kwon EJ, Kim do H.

Biochem J. 2014 Jan 1;457(1):151-62. doi: 10.1042/BJ20130833.

PMID:
24117217
[PubMed - indexed for MEDLINE]
Free Article
11.

MicroRNA-350 induces pathological heart hypertrophy by repressing both p38 and JNK pathways.

Ge Y, Pan S, Guan D, Yin H, Fan Y, Liu J, Zhang S, Zhang H, Feng L, Wang Y, Xu R, Yin JQ.

Biochim Biophys Acta. 2013 Jan;1832(1):1-10. doi: 10.1016/j.bbadis.2012.09.004. Epub 2012 Sep 20.

PMID:
23000971
[PubMed - indexed for MEDLINE]
Free Article
12.

MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.

Tu Y, Wan L, Bu L, Zhao D, Dong D, Huang T, Cheng Z, Shen B.

Cell Physiol Biochem. 2013;31(6):997-1008. doi: 10.1159/000350117. Epub 2013 Jul 2.

PMID:
23860036
[PubMed - indexed for MEDLINE]
13.

Up-regulation of miR-26a promotes apoptosis of hypoxic rat neonatal cardiomyocytes by repressing GSK-3β protein expression.

Suh JH, Choi E, Cha MJ, Song BW, Ham O, Lee SY, Yoon C, Lee CY, Park JH, Lee SH, Hwang KC.

Biochem Biophys Res Commun. 2012 Jun 29;423(2):404-10. doi: 10.1016/j.bbrc.2012.05.138. Epub 2012 Jun 1.

PMID:
22664106
[PubMed - indexed for MEDLINE]
14.

miR-34a modulates angiotensin II-induced myocardial hypertrophy by direct inhibition of ATG9A expression and autophagic activity.

Huang J, Sun W, Huang H, Ye J, Pan W, Zhong Y, Cheng C, You X, Liu B, Xiong L, Liu S.

PLoS One. 2014 Apr 11;9(4):e94382. doi: 10.1371/journal.pone.0094382. eCollection 2014.

PMID:
24728149
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

miR-30a downregulation aggravates pressure overload-induced cardiomyocyte hypertrophy.

Yin X, Peng C, Ning W, Li C, Ren Z, Zhang J, Gao H, Zhao K.

Mol Cell Biochem. 2013 Jul;379(1-2):1-6. doi: 10.1007/s11010-012-1552-z. Epub 2013 May 10.

PMID:
23660952
[PubMed - indexed for MEDLINE]
16.

Regulation of cardiac microRNAs by serum response factor.

Zhang X, Azhar G, Helms SA, Wei JY.

J Biomed Sci. 2011 Feb 8;18:15. doi: 10.1186/1423-0127-18-15.

PMID:
21303526
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Attenuation of microRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy.

Xu XD, Song XW, Li Q, Wang GK, Jing Q, Qin YW.

J Cell Physiol. 2012 Apr;227(4):1391-8. doi: 10.1002/jcp.22852.

PMID:
21618527
[PubMed - indexed for MEDLINE]
18.

Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy.

Yang J, Nie Y, Wang F, Hou J, Cong X, Hu S, Chen X.

Biochim Biophys Acta. 2013 Aug;1831(8):1386-94. doi: 10.1016/j.bbalip.2013.05.005. Epub 2013 May 25.

PMID:
23711961
[PubMed - indexed for MEDLINE]
19.

Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.

Hardt SE, Tomita H, Katus HA, Sadoshima J.

Circ Res. 2004 Apr 16;94(7):926-35. Epub 2004 Mar 4.

PMID:
15001529
[PubMed - indexed for MEDLINE]
Free Article
20.

MicroRNA-328 as a regulator of cardiac hypertrophy.

Li C, Li X, Gao X, Zhang R, Zhang Y, Liang H, Xu C, Du W, Zhang Y, Liu X, Ma N, Xu Z, Wang L, Chen X, Lu Y, Ju J, Yang B, Shan H.

Int J Cardiol. 2014 May 1;173(2):268-76. doi: 10.1016/j.ijcard.2014.02.035. Epub 2014 Feb 28.

PMID:
24631114
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk